Bristol-Myers Squibb is getting the corporate equivalent of a polite shrug from analysts, with most advising investors to ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

Buried in a technical document released by the Centers for Medicare and Medicaid Services is a convoluted paragraph that may ...

The president claimed his “most-favored nation” proposal would reduce some pharmaceutical prices by as much as 80%, but the ...

GSK has stopped development of anti-TIGIT antibody belrestotug. | GSK has stopped development of anti-TIGIT antibody ...

The third cycle of the drug price negotiations will involve drugs under Medicare Part B. New prices are set to take effect in ...

Bristol Myers Squibb (BMY) and MPLX present compelling value picks, offering high-income potential and attractive valuations ...

Older patients with Crohn’s disease are at elevated risk for recurrence following ileocolic resection but less frequently ...

Robert F. Kennedy Jr. cited Bernie Sanders' 2016 and 2020 White House campaign plans on prescription drugs to highlight Trump's efforts in 2025.

Health-care companies rose sharply after President Trump signed an executive order designed to lower what Americans pay for prescription drugs that offered pharmaceutical companies room for ...

Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general’s office announced Friday. A ...

President Donald Trump wants to lower U.S. drug costs by linking prices to those paid in other developed countries – a move ...